Xiao Bin Wu
Vermögen: 32 Mio $ am 28.02.2026
Vermögen: 32 Mio $ am 28.02.2026
Dr. Xiao Bin Wu ist ein unabhängiger Non-Executive Director bei Clover Biopharmaceuticals Ltd, ein President & Chief Operating Officer bei BeiGene Ltd, ein Chairman bei BeiGene Pharmaceuticals (Guangzhou) Co., Ltd, ein Chairman & Manager bei BeiGene (Guangzhou) Co., Ltd. und ein Country Manager-China bei Pfizer Pharmaceuticals Ltd. Er ist Mitglied des Board of Directors bei Clover Biopharmaceuticals Ltd. Er erhielt seinen Diplomabschluss von der Universität Konstanz und promovierte an der Universität Konstanz.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BEONE MEDICINES LTD. 0,08 % | 06.03.2026 | 1.280.781 ( 0,08 % ) | 31 Mio $ | 28.02.2026 |
| 26.09.2025 | 558.000 ( 0,04 % ) | 139 818 $ | 28.02.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BEIGENE LTD | Präsident | 01.04.2018 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Direktor/Vorstandsmitglied | 19.04.2021 |
Pfizer Pharmaceuticals Ltd.
Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Corporate Officer/Principal | 23.08.2011 |
BeiGene Pharmaceuticals (Guangzhou) Co. Ltd.
BeiGene Pharmaceuticals (Guangzhou) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorsitzender | - |
BeiGene (Guangzhou) Co., Ltd.
BeiGene (Guangzhou) Co., Ltd. Financial ConglomeratesFinance Provides investment services | Vorsitzender | - |
China Pharmaceutical Industry Research & Dev. Association | Direktor/Vorstandsmitglied | 01.01.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.04.2018 |
RDPAC
RDPAC Miscellaneous Commercial ServicesCommercial Services Operates as an association dedicated to elevate pharmaceutical innovation ecosystem in China | Direktor/Vorstandsmitglied | 01.01.2018 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Corporate Officer/Principal | 01.01.2009 |
| ░░░░░ ░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Universität Konstanz
Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Pharmaceuticals Ltd.
Pfizer Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Bayer Healthcare Co., Ltd.
Bayer Healthcare Co., Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
China National Association of Industry & Commerce | |
China Pharmaceutical Industry Research & Dev. Association | |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Pfizer Essential Health
Pfizer Essential Health Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
BeiGene (Guangzhou) Co., Ltd.
BeiGene (Guangzhou) Co., Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
BeiGene Pharmaceuticals (Guangzhou) Co. Ltd.
BeiGene Pharmaceuticals (Guangzhou) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
RDPAC
RDPAC Miscellaneous Commercial ServicesCommercial Services Operates as an association dedicated to elevate pharmaceutical innovation ecosystem in China | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition